11.12.2017 • News

Univar to buy Kemetyl Industrial Chemicals

The purchase is the second for Univar this year and follows the takeover of...
The purchase is the second for Univar this year and follows the takeover of Tagma Brasil in September. (c) Univar

Univar’s wholly owned subsidiaries in Sweden and Norway have agreed to acquire Kemetyl Industrial Chemicals for an undisclosed sum. The acquisition is expected to close in early 2018.

Headquartered in Haninge, Sweden, Kemetyl distributes bulk and specialty chemicals, including isopropanol, glycols, metal salts, minerals and polyacrylamides in the Nordic region. The company is also one of the region’s largest suppliers of industrial-grade alcohols, including its own brand Sekundol, which is derived from recycled ethanol and used as a carbon source in the wastewater treatment process.

“The Nordic region is at the forefront of global R&D when it comes to life sciences, which makes this agreement a smart and strategic move to build our customer base and enhance our market expertise. This acquisition will allow Univar to expand its leading position in pharma and strengthen its expertise in water treatment,” said Steve Newlin, Univar’s chairman and CEO.

Kemetyl group’s chairman, Ketil Stave, added that the divestment is a logical step in its strategy to further focus on consumer chemicals.

The purchase is the second for Univar this year and follows the takeover of Tagma Brasil in September. Based in Sao Paulo, Tagma provides custom formulation and packaging services for crop protection chemicals.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read